Back | Next |
home / stock / tlsa / tlsa message board
Subject | By | Source | When |
---|---|---|---|
Price trading last trade up | Crusader | investorshub | 09/24/2023 4:15:12 AM |
$TLSA news out | Count Crypto | investorshub | 09/24/2023 3:10:37 AM |
$TLSA MomentumIts gaining last up | ClayTrader | investorshub | 09/24/2023 1:05:14 AM |
MomentumIts gaining last up | ElvisCobain | investorshub | 09/23/2023 11:45:30 PM |
The now up | Steve200747909 | investorshub | 09/23/2023 11:11:21 PM |
$TLSA bears are running | mfayman | investorshub | 09/23/2023 8:52:10 PM |
The trading | Ryguy008 | investorshub | 09/23/2023 6:46:16 PM |
great news | Anita Dump | investorshub | 09/23/2023 4:20:01 PM |
$TLSA short data if anyone is interested | Anita Dump | investorshub | 09/23/2023 1:55:40 PM |
$TLSA what do you make of this data? | Count Crypto | investorshub | 09/23/2023 12:15:05 PM |
$TLSA Time for a bounce? | doolz | investorshub | 09/23/2023 8:52:50 AM |
$TLSA The trading | Crusader | investorshub | 09/23/2023 6:26:45 AM |
Do we have a winner?Turn around time? | Count Crypto | investorshub | 09/23/2023 6:24:21 AM |
$TLSA What do you make of this? | Count Crypto | investorshub | 09/23/2023 2:10:23 AM |
$TLSA When is this gonna take off? | Count Crypto | investorshub | 09/23/2023 1:59:58 AM |
Looks pretty positive | Count Crypto | investorshub | 09/23/2023 1:12:17 AM |
The gaining | The Night Stalker | investorshub | 09/22/2023 9:28:00 PM |
$TLSA Time for this to show some returns | mfayman | investorshub | 09/22/2023 6:22:08 PM |
$TLSA good read | Count Crypto | investorshub | 09/22/2023 6:22:07 PM |
$TLSA The trading | The Night Stalker | investorshub | 09/22/2023 5:05:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
10.0%Change Percent:
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ant...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...